The Skin Cancer Education and Research Foundation – Home › Forums › Immunotherapy › Dosing and administration › Infusion times › Reply To: Infusion times
I agree with Krista that we have seen a big increase in volume with nivolumab now being used in the adjuvant setting. We still give ipilimumab over 90 minutes, nivolumab over 60 minutes and pembrolizumab over 30 minutes. It sounds like we are behind with adjusting infusion times, but I will talk with our pharmacy about adjusting them. Thanks for the tip!